Neoleukin Therapeutics NLTX

$ 3.49 0.0%

Quarterly report 2024-Q3
added 11-18-2024

Neoleukin Therapeutics EV/EBITDA Ratio 2011-2024 | NLTX

Annual EV/EBITDA Ratio Neoleukin Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
0.202	-10.3	-7.63	0.77	-5.04	-8.11	-4.29	-3.46	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
0.77	-10.3	-4.73